Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.

MLA

Fumagalli, Debora, et al. “Transfer of Clinically Relevant Gene Expression Signatures in Breast Cancer: From Affymetrix Microarray to Illumina RNA-Sequencing Technology.” BMC Genomics, vol. 15, no. 1, Dec. 2014, pp. 1–28. EBSCOhost, https://doi.org/10.1186/1471-2164-15-1008.

APA

Fumagalli, D., Blanchet-Cohen, A., Brown, D., Desmedt, C., Gacquer, D., Michiels, S., Rothé, F., Majjaj, S., Salgado, R., Larsimont, D., Ignatiadis, M., Maetens, M., Piccart, M., Detours, V., Sotiriou, C., & Haibe-Kains, B. (2014). Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology. BMC Genomics, 15(1), 1–28. https://doi.org/10.1186/1471-2164-15-1008

Chicago

Fumagalli, Debora, Alexis Blanchet-Cohen, David Brown, Christine Desmedt, David Gacquer, Stefan Michiels, Françoise Rothé, et al. 2014. “Transfer of Clinically Relevant Gene Expression Signatures in Breast Cancer: From Affymetrix Microarray to Illumina RNA-Sequencing Technology.” BMC Genomics 15 (1): 1–28. doi:10.1186/1471-2164-15-1008.